https://www.selleckchem.com/pr....oducts/b102-parp-hda
We aimed to test whether type 2 diabetes (T2D)-associated genetic variants affect insulin sensitivity or secretion in autoantibody-positive relatives at risk for type 1 diabetes (T1D). We studied autoantibody-positive TrialNet Pathway to Prevention study participants ( = 1,061) (mean age 16.3 years) with single nucleotide polymorphism (SNP) information and baseline oral glucose tolerance test (OGTT) to calculate indices of insulin sensitivity and secretion. With Bonferroni correction for multiple comparisons, values 0.0
Like
Comment
Share
